Trupanion (NASDAQ:TRUP) Hits New 52-Week Low – Should You Sell?

Trupanion, Inc. (NASDAQ:TRUP) reached a new 52-week low during trading on Thursday . The company traded as low as $24.44 and last traded at $24.3250, with a volume of 93890 shares traded. The stock had previously closed at $25.68.

Wall Street Analyst Weigh In

Several brokerages have issued reports on TRUP. Stifel Nicolaus cut their price objective on Trupanion from $38.00 to $35.00 and set a “hold” rating for the company in a research report on Friday, February 13th. Cantor Fitzgerald lowered their target price on Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Weiss Ratings downgraded shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 4th. Finally, Wall Street Zen cut shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Trupanion has an average rating of “Hold” and an average price target of $45.50.

Trupanion Stock Down 4.1%

The business’s fifty day simple moving average is $30.11 and its 200 day simple moving average is $36.67. The stock has a market cap of $1.07 billion, a price-to-earnings ratio of 54.53 and a beta of 1.62. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.01). The firm had revenue of $376.85 million during the quarter, compared to the consensus estimate of $375.89 million. Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The firm’s revenue for the quarter was up 11.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.04 EPS. Equities analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Insider Transactions at Trupanion

In related news, COO John R. Gallagher sold 5,283 shares of the firm’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $26.52, for a total transaction of $140,105.16. Following the completion of the transaction, the chief operating officer directly owned 32,387 shares of the company’s stock, valued at $858,903.24. This trade represents a 14.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CRO Emily Dreyer sold 7,792 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $28.15, for a total value of $219,344.80. Following the sale, the executive owned 35,627 shares in the company, valued at approximately $1,002,900.05. The trade was a 17.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 31,107 shares of company stock worth $949,347 over the last quarter. 5.42% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Trupanion

Several hedge funds have recently modified their holdings of TRUP. Campbell & CO Investment Adviser LLC purchased a new position in shares of Trupanion in the third quarter worth approximately $3,772,000. GSA Capital Partners LLP lifted its position in Trupanion by 827.3% during the third quarter. GSA Capital Partners LLP now owns 44,584 shares of the financial services provider’s stock valued at $1,930,000 after purchasing an additional 39,776 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Trupanion by 66.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 161,781 shares of the financial services provider’s stock valued at $8,955,000 after buying an additional 64,704 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Trupanion during the 3rd quarter valued at approximately $1,897,000. Finally, Kopion Asset Management LLC boosted its stake in shares of Trupanion by 20.8% in the third quarter. Kopion Asset Management LLC now owns 264,603 shares of the financial services provider’s stock worth $11,452,000 after acquiring an additional 45,594 shares during the period.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.